Pharmacy and Poison Board bans Neotack drug
The Kenya Pharmacy and Poisons Board has withdrawn anti-acid Ranitidine drug over concerns that it was linked to cancer in the United States of America.
The anti-acid Ranitidine is known as Neotack in Kenya.
The U.s Food and Drug Administration (FDA) stated that the popular heartburn drug ranitidine contained small amounts N-nitrosodimethylamine (NDMA), which the regulator says is a “probable human carcinogen.
Kenya has joined a list of drug manufacturers across the world have begun recalling the widely taken heartburn drug.
Do you have any news or article you would like us to publish? Kindly reach us via email@example.com or firstname.lastname@example.org.